Related Experiment Videos
HLA-derived peptides as novel immunotherapeutics
1Department of Pediatrics, Stanford University, California 94305, USA.
Clinical Immunology and Immunopathology
|May 1, 1995
Summary
Synthetic HLA peptides may offer a novel approach to immune tolerance. These molecules modulate T cell responses by interacting with heat-shock proteins, potentially explaining transfusion effects and aiding transplant success.
Area of Science:
- Immunology
- Transplantation Biology
- Molecular Medicine
Background:
- Soluble human leukocyte antigen (HLA) molecules may act as natural immunoregulators.
- The
- transfusion effect
- in transplant patients historically suggests immune modulation.
- Synthetic HLA peptides have shown potential in modulating immune responses.
Purpose of the Study:
- To investigate the immunoregulatory mechanisms of synthetic HLA peptides.
- To explore the role of these peptides in T cell modulation and transplant tolerance.
- To elucidate the molecular interactions underlying peptide activity.
Main Methods:
- In vitro studies on human T lymphocytes.
- In vivo heterotopic heart transplant model in rats.
- Analysis of intracellular calcium levels in T cells.
- Investigation of peptide binding to heat-shock protein 70 (HSP70) family members.
Main Results:
- Synthetic HLA peptides demonstrated inhibitory effects on human T lymphocytes.
- These peptides induced tolerance in a rat heart transplant model.
- A subset of peptides increased intracellular calcium, leading to T cell unresponsiveness.
- Specific peptide sequences dictated binding to HSP70 family members.
Conclusions:
- Synthetic HLA peptides possess immunotherapeutic potential.
- The mechanism involves T cell modulation via intracellular calcium increase and HSP70 binding.
- These findings provide a basis for developing novel immunotherapeutic strategies for transplantation.